Search - tctmd.com

Displaying 81 - 100 of 584

Sort: Relevancy | Date

Podcast TCTMD Talking Points

The ENVISAGE-TAVI AF Trial

December 07, 2022

Podcast TCTMD Talking Points

The LOOP Study for AF Screening

December 04, 2022

Podcast TCTMD Talking Points

The FIGARO-DKD Trial

November 23, 2022

Podcast TCTMD Talking Points

AMULET-IDE: One-Year Outcomes

November 09, 2022

Podcast TCTMD Talking Points

Shock Classification Gets an Update

November 02, 2022

Podcast TCTMD Talking Points

MICHELLE: Rivaroxaban in COVID-19

October 19, 2022

Podcast TCTMD Talking Points

The RIPCORD 2 Trial

October 05, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Podcast TCTMD Talking Points

PARTNER 3: Two-Year Economic Outcomes

September 14, 2022

Podcast TCTMD Talking Points

The IAMI Trial

September 07, 2022

Podcast TCTMD Talking Points

Two DCBs Go Head to Head in De Novo CAD

August 24, 2022

Podcast TCTMD Talking Points

The EMPEROR-Preserved Trial

August 10, 2022

Podcast TCTMD Talking Points

iFR-SWEDEHEART at 5 Years

August 03, 2022

Podcast TCTMD Talking Points

PRONOUNCE: Prostate Cancer Drugs and CVD

July 20, 2022

Podcast TCTMD Talking Points

The TOMAHAWK Trial

July 06, 2022

Podcast TCTMD Talking Points

The OPTIMUM Trial

June 22, 2022

Podcast TCTMD Talking Points

The MASTER DAPT Trial

June 08, 2022

Podcast TCTMD Talking Points

The EROSION III Trial

June 01, 2022

Advertisement

The ENVISAGE-TAVI AF Trial

The LOOP Study for AF Screening

The FIGARO-DKD Trial

AMULET-IDE: One-Year Outcomes

Shock Classification Gets an Update

MICHELLE: Rivaroxaban in COVID-19

The RIPCORD 2 Trial

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

PARTNER 3: Two-Year Economic Outcomes

The IAMI Trial

Two DCBs Go Head to Head in De Novo CAD

The EMPEROR-Preserved Trial

iFR-SWEDEHEART at 5 Years

PRONOUNCE: Prostate Cancer Drugs and CVD

The TOMAHAWK Trial

The OPTIMUM Trial

The MASTER DAPT Trial

The EROSION III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content